Delivery Order SPE2DR25D3005-SPE2DR26FP7FG
- Not listed
- The Defense Logistics Agency awarded a $11,577.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,392.50 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,618.92 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply requirement under the federal medical procurement system supporting military and veteran healthcare needs....
- The Defense Logistics Agency awarded a delivery order valued at $1,149.50 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as a hub for the company's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,614.03 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,960.21 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 7, 2025. The contract employs firm fixed-price pricing and was awarded competitively without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which represents a single transaction under a larger DLA Troop...
- The Defense Logistics Agency awarded a $5,181.96 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceuticals, with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,826.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7FGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,080.56 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, PA. This delivery order represents a drawdown against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. REPATHA is a prescription medication used for cholesterol management and cardiovascular disease prevention, commonly supplied through the Defense Health Agency's medical supply chain to support military healthcare programs. AmerisourceBergen's position as a prime pharmaceutical vendor to the DLA reflects its established capability to deliver specialized medications and medical supplies across multiple therapeutic domains to federal healthcare systems, including the Department of Defense and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 11/14/25 |